Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Stearoyl polyoxyethylene glycerol ester stands out among non-ionic surfactants, holding a unique role in pharma manufacturing and development. Its backbone builds on stearic acid, a fatty acid, combined with polyoxyethylene chains, bonded to glycerol. This combination gives the compound both hydrophilic and lipophilic properties, making it a practical emulsifier and solubilizer across a range of pharmaceutical applications. Common trade forms include flakes, powders, pearls, and sometimes viscous liquids, catering to specific tech flows in solid, semi-solid, or liquid pharmaceutical products.
In the pharma setting, the distinction BP, EP, USP shows the ingredient meets strict guideline criteria provided by the British, European, and United States pharmacopeias. Compliance ensures batch uniformity, high purity, and verified safety. Pharmaceutical scientists rely on this raw material to blend water and oil-based components, allowing active compounds to distribute evenly across suspensions, creams, ointments, or oral solutions. Without a reliable surfactant like stearoyl polyoxyethylene glycerol ester, tablets can crumble, solutions might look cloudy, and shelf life often shortens.
At the molecular level, this compound belongs to the class of stearate esters with polyoxyethylene chains, and features a glyceryl core. The structure consists of a long stearic acid tail, which provides the fatty characteristic, while polyoxyethylene groups wrap around the backbone, boosting water compatibility. The general chemical formula is C18H35CO(OCH2CH2)nOCH2CHOHCH2OH, with "n" marking the number of ethylene oxide units — typically stated on product specification sheets. The unique structure allows the molecule to act both as an emulsifier, keeping oil and water mixed, and sometimes as a stabilizing or solubilizing agent.
From a raw materials perspective, each batch roots back to high-grade stearic acid and pharmaceutical polyoxyethylene glycol, which ensures minimal contamination and reliable batch reproducibility. Chemists overseeing production must verify molecular distribution, ensuring that the average polyoxyethylene chain length matches product specifications. Such control points help prevent issues like batch failures or failing pharmacopoeia compliance tests.
Stearoyl polyoxyethylene glycerol ester usually appears as off-white to light yellow flakes, powder, or pearl-like granules, largely depending on manufacturing technique and market demand. The material can also be processed into a thick, viscous liquid for solution-based pharma applications. The typical density sits around 0.98–1.05 g/cm3 at 20°C, but specifications will always provide a tight range, as consistent density supports proper blending and ensures volume measurements translate to accurate dosages.
Melting points often range from 40°C to 60°C. This property signals ease of handling, storage, and blending into molten pharmaceutical matrices, such as those used in controlled-release drug forms. Moisture content, measured as loss on drying, remains tightly controlled, as excessive water can lead to clumping, microbial risk, or reduced shelf stability. On any specification sheet for pharma grade, expect entries for appearance, solubility in water or alcohol, melting point, acid or saponification value, and loss on drying. These characteristics assure manufacturers and regulators that the material will not degrade during processing or lose its emulsifying punch over time.
For customs, import, and logistics professionals shipping this material globally, the Harmonized System (HS) Code often assigned is 340213. This designation applies to non-ionic organic surface-active agents. Correct HS Code usage underpins global trade transparency, letting buyers, sellers, and regulators track and tax consignments accurately. It helps producers keep up with regulatory obligations and supports smooth customs clearance, especially for pharma ingredients that need rapid shipping under controlled environments.
Different supply forms — from solid flakes to powders, pearl granules, or syrupy liquids — give pharmaceutical technologists flexibility when developing or producing medicines. Flakes dissolve slowly but guarantee steady dispersion during hot processing. Powder form supports quick wettability and can speed up blending in dry environments. Pearl and granule options reduce dust, making the compound safer for high-volume processing lines. Liquids, typically semi-viscous, suit continuous-feed mixing and allow dosing control in solution-based products. Crystal forms are less common in pharmaceuticals, appearing mostly in specialty custom grades for targeted purposes.
Across all these physical forms, the key properties must align with pharmaceutical needs: rapid hydration for wet granulation, minimal residue, and high purity. Storage conditions call for sealed containers away from heat, moisture, and light to maintain structure and avoid breakdown. Unexpected shifts in texture or color usually point to exposure or contamination, signaling cause for a quality audit.
Density plays an essential role for those working on formula scale-up, pilot plant batches, or final production runs. The standard range ensures material tracks correctly on automated dosing lines and matches weight-to-volume calculations in finished formulations. For those preparing liquid solutions, typical concentrations vary from 1% up to 10%, depending on the solubility needs and product requirements. The chemical dissolves well in warm water, ethanol, and some glycols, while high-polyoxyethylene grades may take longer to disperse in cold water. Technicians pay attention to slow addition rates, agitation levels, and temperature, all to prevent clumping and guarantee smooth dissolutions.
Safety data on stearoyl polyoxyethylene glycerol ester shows it is broadly considered low in toxicity when handled according to good manufacturing practice, especially in its pharma grade. Direct skin or eye contact rarely triggers strong irritation, but plant workers still use protective gear to avoid splashes and prevent build-up on equipment or floors. Ingestion at intended doses in medicines aligns with international toxicology limits, and chronic exposure risks stay low. With that said, containers or dust clouds need management to avoid inhalation risk or electrical fire concerns, especially in dry, powdery environments. No hazardous decomposition at ambient temperatures, but overheating or improvised mixing might lead to fume generation. Waste material should move through approved disposal for non-hazardous, non-bioaccumulative substances.
Finished pharmaceutical products using this material must pass residual solvent, trace element, and allergen testing before market release. Batch traceability and retention samples also stand as routine practice in regulatory-compliant facilities, guarding patient safety and consumer trust.
Makers of stearoyl polyoxyethylene glycerol ester select high-purity stearic acid sourced from vegetal or certified animal origins, polyoxyethylene glycol with consistent chain length, and pharmaceutical-grade glycerol. Every input undergoes rigorous QC testing. Pharmaceutical facility supply chains look for continuous certification, allergen-control documentation, and up-to-date GMP adherence from suppliers, reducing audit risk and keeping product recalls at bay.
As pharmaceutical science continues to raise standards and patients demand transparent sourcing, manufacturers face pressure to declare origin, provide COA with each lot, and maintain complete supply chain visibility. Adopting blockchain or ERP-powered traceability systems stands out as a best practice for those seeking to comply with new international requirements and GxP recommendations.
Chengguan District, Lanzhou, Gansu, China
